Improved health outcomes, and at community level reduced transmission risk.

Determine predictors of early treatment and monitor the rate of adoption of early treatment.

Data source is most of the 83 clinics in Australia, analysis by the Kirby Institute.

Include diagnoses from 2004 to 2015.

Excluded inconsistent or incomplete records.

863 patients in the analysis.

Median CD4 count was 500.

Viral load higher in the earlier time period of the study.

Predictors of early treatment were low CD4 count, high viral load, and later year of the study.

Sociodemographic characteristics were not associated with early treatment.